新华医疗拟出售华检医疗不超过5%股份

Core Viewpoint - Xinhua Medical (600587) announced plans to sell up to 5% of its subsidiary Huajian Medical Holdings through public market transactions to focus on core business development and improve asset operation efficiency [1] Group 1: Company Actions - The full subsidiary Huatuo International Development Co., Ltd. intends to sell no more than 5% of Huajian Medical's shares [1] - The sale will be executed through various public market trading methods, including continuous bidding, collective bidding, and block trading [1] - The company will implement the reduction plan gradually based on a reasonable assessment of Huajian Medical's stock price and market trends [1]